Sarizotan Hydrochloride ( DrugBank: Sarizotan )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	8
156	レット症候群	1

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2005-000444-84-GB (EUCTR)	23/11/2005	13/09/2005	An open-label, multicenter, multinational Phase III follow-up study to investigate the long-term saf ...	An open-label, multicenter, multinational Phase III follow-up study to investigate the long-term saf ...	Treatment-Associated Dyskinesia in Parkinson's Disease	Product Code: EMD128130 INN or Proposed INN: Sarizotan hydrochloride	Merck KGaA	NULL	Not Recruiting	Female: yes Male: yes	800	Phase 3	Finland;Spain;Austria;Italy;United Kingdom
2	EUCTR2005-000444-84-FI (EUCTR)	08/09/2005	26/07/2005	An open-label, multicenter, multinational Phase III follow-up study to investigate the long-term saf ...	An open-label, multicenter, multinational Phase III follow-up study to investigate the long-term saf ...	Treatment-Associated Dyskinesia in Parkinson's Disease	Product Code: EMD128130 INN or Proposed INN: Sarizotan hydrochloride	Merck KGaA	NULL	Not Recruiting	Female: yes Male: yes	800	Phase 3	Finland;United Kingdom;Spain;Italy
3	EUCTR2005-000444-84-ES (EUCTR)	12/07/2005	22/05/2006	An open-label, multicenter, multinational Phase IIIfollow-up study to investigate the long-term safe ...	An open-label, multicenter, multinational Phase IIIfollow-up study to investigate the long-term safe ...	Treatment- Associated Dyskinesia in Parkinson´s Disease	Product Code: EMD128130 INN or Proposed INN: Sarizotan hydrochloride	Merck KGaA	NULL	Not Recruiting	Female: yes Male: yes	800	Phase 3	Finland;Spain;Austria;Italy;United Kingdom
4	EUCTR2005-000444-84-AT (EUCTR)	22/06/2005	18/05/2005	An open-label, multicenter, multinational Phase III follow-up study to investigate the long-term saf ...	An open-label, multicenter, multinational Phase III follow-up study to investigate the long-term saf ...	Treatment-Associated Dyskinesia in Parkinson's Disease	Product Code: EMD128130 INN or Proposed INN: Sarizotan hydrochloride	Merck KGaA	NULL	Not Recruiting	Female: yes Male: yes	800	Phase 3	Finland;Spain;Austria;Italy;United Kingdom
5	EUCTR2004-001594-25-AT (EUCTR)	02/02/2005	29/12/2004	A double-blind, placebo-controlled, multicenter, multinational Phase III study to evaluate the safet ...	A double-blind, placebo-controlled, multicenter, multinational Phase III study to evaluate the safet ...	Treatment-Associated Dyskinesia in Parkinson's Disease	Product Code: EMD128130 INN or Proposed INN: Sarizotan hydrochloride	Merck KGaA	NULL	Not Recruiting	Female: yes Male: yes	600	Phase 3	Finland;Spain;Austria
6	EUCTR2004-001594-25-FI (EUCTR)	30/12/2004	26/10/2004	A double-blind, placebo-controlled, multicenter, multinational Phase III study to evaluate the safet ...	A double-blind, placebo-controlled, multicenter, multinational Phase III study to evaluate the safet ...	Treatment-Associated Dyskinesia in Parkinson's Disease	Product Code: EMD128130 INN or Proposed INN: Sarizotan hydrochloride	Merck KGaA	NULL	Not Recruiting	Female: yes Male: yes	600	Phase 3	Finland;Spain
7	EUCTR2004-001593-10-IT (EUCTR)	02/12/2004	03/01/2005	A double-blind, placebo-controlled, multicenter, multinational Phase III study to evaluate the safet ...	A double-blind, placebo-controlled, multicenter, multinational Phase III study to evaluate the safet ...	Treatment-Associated Dyskinesia in Parkinson's Disease	Product Name: Sarizotan hydrochloride Product Code: EMD 128130 INN or Proposed INN: Sarizotan hydrochl ...	MERCK S.P.A.	NULL	Not Recruiting	Female: yes Male: yes		Phase 3	United Kingdom;Italy
8	EUCTR2004-001594-25-ES (EUCTR)	24/11/2004	02/11/2004	A double-blind, placebo controlled, multicenter, multinational, phase III study to evaluate the safe ...	A double-blind, placebo controlled, multicenter, multinational, phase III study to evaluate the safe ...	Treatment-Associated Dyskinesia in Parkinson's Disease	Product Name: Sarizotan Product Code: EMD 128130 INN or Proposed INN: Sarizotan Hydrochloride	MERCK KGaA	NULL	Not Recruiting	Female: yes Male: yes	600	Phase 3	Finland;Spain;Austria

First Previous1Next Last

先頭へ

156. レット症候群

臨床試験数 : 44 / 薬物数 : 61 - (DrugBank : 23) / 標的遺伝子数 : 57 - 標的パスウェイ数 : 83

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-004448-20-GB (EUCTR)	28/11/2016	23/09/2016	Sarizotan: Treatment in patients with Rett Syndrome with Respiratory Symptoms.	A Randomized, Double-Blind, Placebo-Controlled, Six-Month Study to Evaluate the Efficacy, Safety and ...	Rett syndrome MedDRA version: 20.0;Level: LLT;Classification code 10039000;Term: Rett's disorder;Sys ...	Product Name: sarizotan hydrochloride Product Code: EMD 128130 INN or Proposed INN: sarizotan hydrochl ...	Newron Pharmaceuticals S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	129	Phase 2	United States;Australia;Italy;United Kingdom;India

First Previous1Next Last

先頭へ